Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV
Anemia is the most common hematological disorder associated with Human Immunodeficiency Virus (HIV). WHO recommends zidovudine (AZT) as one of the first-line drugs for this infection. It is important to note that the drug has the adverse effect of causing anemia. Therefore, this study correlates AZT...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Sanata Dharma
2023-05-01
|
Series: | Jurnal Farmasi Sains dan Komunitas |
Subjects: | |
Online Access: | https://e-journal.usd.ac.id/index.php/JFSK/article/view/4331 |
_version_ | 1797785711412248576 |
---|---|
author | Danis Pertiwi Muchlis Achsan Udji Sofro Tri Indah Winarni Ari Natalia Probandari |
author_facet | Danis Pertiwi Muchlis Achsan Udji Sofro Tri Indah Winarni Ari Natalia Probandari |
author_sort | Danis Pertiwi |
collection | DOAJ |
description | Anemia is the most common hematological disorder associated with Human Immunodeficiency Virus (HIV). WHO recommends zidovudine (AZT) as one of the first-line drugs for this infection. It is important to note that the drug has the adverse effect of causing anemia. Therefore, this study correlates AZT consumption duration and the incidence of anemia in HIV-infected individuals. This cross-sectional study was conducted at health service facilities using 213 participants. The data were obtained from medical records, and the assessed parameter was hemoglobin (Hb) level after less or more than a year of zidovudine administration. Furthermore, they were analyzed using a Pearson’s coefficient contingency test (p0.05) to evaluate the correlation between groups with and without anemia at each period of drug administration. The results showed a significant correlation (p0.05) between sex and age with anemia incidence in HIV patients administered AZT. The duration of this drug intake in HIV-infected individuals was correlated with anemia (p= 0.024; OR=0.369). This indicates the use of AZT for at least one year may be a protective factor for the incidence of anemia in patients with HIV compared to the group consuming this drug for less than one year. |
first_indexed | 2024-03-13T00:58:49Z |
format | Article |
id | doaj.art-2a8a8cfd5422446f9a8ab92f64417e1f |
institution | Directory Open Access Journal |
issn | 1693-5683 2527-7146 |
language | English |
last_indexed | 2024-03-13T00:58:49Z |
publishDate | 2023-05-01 |
publisher | Universitas Sanata Dharma |
record_format | Article |
series | Jurnal Farmasi Sains dan Komunitas |
spelling | doaj.art-2a8a8cfd5422446f9a8ab92f64417e1f2023-07-06T13:56:39ZengUniversitas Sanata DharmaJurnal Farmasi Sains dan Komunitas1693-56832527-71462023-05-01201465110.24071/jpsc.0043312950Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIVDanis Pertiwi0Muchlis Achsan Udji Sofro1Tri Indah Winarni2Ari Natalia Probandari3Department of Clinical Pathology, Faculty of Medicine, Universitas Islam Sultan Agung, Semarang, IndonesiaDivision of Tropical Medicine Department of Internal Medicine Dr Kariadi Hospital, Faculty of Medicine Universitas Diponegoro, Semarang, IndonesiaDepartment of Anatomy, Faculty of Medicine, Universitas Diponegoro, Semarang, IndonesiaDepartment of Public Health, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, IndonesiaAnemia is the most common hematological disorder associated with Human Immunodeficiency Virus (HIV). WHO recommends zidovudine (AZT) as one of the first-line drugs for this infection. It is important to note that the drug has the adverse effect of causing anemia. Therefore, this study correlates AZT consumption duration and the incidence of anemia in HIV-infected individuals. This cross-sectional study was conducted at health service facilities using 213 participants. The data were obtained from medical records, and the assessed parameter was hemoglobin (Hb) level after less or more than a year of zidovudine administration. Furthermore, they were analyzed using a Pearson’s coefficient contingency test (p0.05) to evaluate the correlation between groups with and without anemia at each period of drug administration. The results showed a significant correlation (p0.05) between sex and age with anemia incidence in HIV patients administered AZT. The duration of this drug intake in HIV-infected individuals was correlated with anemia (p= 0.024; OR=0.369). This indicates the use of AZT for at least one year may be a protective factor for the incidence of anemia in patients with HIV compared to the group consuming this drug for less than one year.https://e-journal.usd.ac.id/index.php/JFSK/article/view/4331hivanemiazidovudine consumptionduration |
spellingShingle | Danis Pertiwi Muchlis Achsan Udji Sofro Tri Indah Winarni Ari Natalia Probandari Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV Jurnal Farmasi Sains dan Komunitas hiv anemia zidovudine consumption duration |
title | Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV |
title_full | Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV |
title_fullStr | Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV |
title_full_unstemmed | Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV |
title_short | Duration of Zidovudine Consumption Correlates with Anemia in People Living with HIV |
title_sort | duration of zidovudine consumption correlates with anemia in people living with hiv |
topic | hiv anemia zidovudine consumption duration |
url | https://e-journal.usd.ac.id/index.php/JFSK/article/view/4331 |
work_keys_str_mv | AT danispertiwi durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv AT muchlisachsanudjisofro durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv AT triindahwinarni durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv AT arinataliaprobandari durationofzidovudineconsumptioncorrelateswithanemiainpeoplelivingwithhiv |